Aiming at the Right Targets on Drug Price Reform.

Stacie B Dusetzina

Published in: The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics (2024)

A lack of transparency and concerns over patients costs at the pharmacy counter have increased Congressional focus on pharmacy benefits management practices. However, applying regulations without transparency into pharmacy benefits managers practices could do more harm than good.

Keyphrases

primary care
end stage renal disease
healthcare
chronic kidney disease
newly diagnosed
ejection fraction
emergency department
health insurance
patient reported outcomes
drug induced
affordable care act